{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:09:01Z","timestamp":1785431341266,"version":"3.56.0"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019D00021"],"award-info":[{"award-number":["75N93019D00021"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201700041I"],"award-info":[{"award-number":["HHSN272201700041I"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2025,12,23]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The Crimean-Congo hemorrhagic fever orthonairovirus (CCHFV) is a widespread tick-borne agent that causes severe disease in humans. Its expanding geographic range poses a significant public health threat. Although animal models for CCHFV infection have been developed, the requirement for maximum biosafety level 4 facilities limits the development of countermeasures against the virus. Hazara virus (HAZV) is a closely related orthonairovirus that can be handled in biosafety level 2 containment and has been proposed as a prototype virus for the\n                      <jats:italic toggle=\"yes\">Orthonairovirus<\/jats:italic>\n                      genus to facilitate early-stage countermeasure development against the highly pathogenic CCHFV. Here, we present a detailed characterization of HAZV infection in mice deficient in type I interferon signaling (\n                      <jats:italic toggle=\"yes\">\n                        Ifnar\n                        <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      <\/jats:italic>\n                      ), providing insights into the natural history of orthonairovirus disease and highlighting similarities and differences between the HAZV and previously described CCHFV mouse infection models. We then utilized the HAZV mouse infection model to test the efficacy of a promising broad-spectrum antiviral, 4\u2032-fluorouridine (4\u2032-FlU). Our findings demonstrate that delayed intervention with orally administered 4\u2032-FlU can rescue clinically ill mice following challenge with a lethal dose of HAZV, supporting further investigations of the compound\u2019s efficacy in CCHF disease models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>\n                      The Crimean-Congo hemorrhagic fever orthonairovirus poses a significant public health threat, underscored by the expansion of\n                      <jats:italic toggle=\"yes\">Hyalomma<\/jats:italic>\n                      genus tick vectors and the lack of clinically proven therapeutic options. The related Hazara orthonairovirus (HAZV), which has not been reported to cause human disease, has been proposed as a prototype virus for the\n                      <jats:italic toggle=\"yes\">Nairoviridae<\/jats:italic>\n                      family. Here, we characterize in detail the mouse model of lethal HAZV disease to gain further insight into nairovirus pathogenesis and use the model for the preclinical development of a promising broad-spectrum antiviral drug candidate, 4\u2032-fluorouridine (4\u2032-FlU). Our findings highlight the value of HAZV as a surrogate for proof-of-concept studies supporting early-stage antiviral drug studies and the therapeutic potential of 4\u2032-FlU for the treatment of often-fatal Crimean-Congo hemorrhagic fever.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/jvi.01421-25","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:00:41Z","timestamp":1763470841000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Pathogenesis of Hazara orthonairovirus infection in type I interferon receptor-deficient mice and resolution of disease following 4\u2032-fluorouridine therapy"],"prefix":"10.1128","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9428-3337","authenticated-orcid":false,"given":"Justin S.","family":"Murray","sequence":"first","affiliation":[{"name":"Department of Animal, Dairy and Veterinary Sciences, Utah State University","place":["Logan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna B.","family":"Westover","sequence":"additional","affiliation":[{"name":"Department of Animal, Dairy and Veterinary Sciences, Utah State University","place":["Logan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionna","family":"Scharton","sequence":"additional","affiliation":[{"name":"Department of Animal, Dairy and Veterinary Sciences, Utah State University","place":["Logan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud J.","family":"Van Wettere","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00h6set76","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Veterinary and Clinical Life Sciences, Utah State University","place":["Logan, USA"]},{"name":"Utah Veterinary Diagnostic Laboratory","place":["Logan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Kolykhalov","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03czfpz43","id-type":"ROR","asserted-by":"publisher"}],"name":"Emory Institute for Drug Development, Emory University","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Mao","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03czfpz43","id-type":"ROR","asserted-by":"publisher"}],"name":"Emory Institute for Drug Development, Emory University","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Natchus","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03czfpz43","id-type":"ROR","asserted-by":"publisher"}],"name":"Emory Institute for Drug Development, Emory University","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Painter","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03czfpz43","id-type":"ROR","asserted-by":"publisher"}],"name":"Emory Institute for Drug Development, Emory University","place":["Atlanta, USA"]},{"name":"Drug Innovation Ventures at Emory (DRIVE)","place":["Atlanta, USA"]},{"id":[{"id":"https:\/\/ror.org\/018rbev86","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pharmacology and Chemical Biology, Emory University","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9113-2575","authenticated-orcid":true,"given":"Brian B.","family":"Gowen","sequence":"additional","affiliation":[{"name":"Department of Animal, Dairy and Veterinary Sciences, Utah State University","place":["Logan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.07.006"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01069-24"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16189.1"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00871-9"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2020.101403"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.09.009"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63906"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01383-10"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit061"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0141-7"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac338"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.038455-0"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj5508"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011342"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00132-24"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado7034"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106122"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000469468"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00798356"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69054-3"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105703"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24312"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00530-09"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008637"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008050"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.850"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.JJID.2014.566"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01672-3"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008183"},{"key":"e_1_3_5_31_2","first-page":"839","article-title":"Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis","volume":"121","author":"Burt FJ","year":"1997","unstructured":"Burt FJ, Swanepoel R, Shieh WJ, Smith JF, Leman PA, Greer PW, Coffield LM, Rollin PE, Ksiazek TG, Peters CJ, Zaki SR. 1997. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 121:839\u2013846.","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.supplement_4.s794"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2007.09.010"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.4274\/eajem.galenos.2020.37039"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2023-0330"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106114"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104858"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.06.013"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-4338-9_15"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2011.08.002"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01421-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.01421-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:04:43Z","timestamp":1766498683000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.01421-25"}},"subtitle":[],"editor":[{"given":"Ryan A.","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,23]]}},"alternative-id":["10.1128\/jvi.01421-25"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01421-25","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"2025-08-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01421-25"}}